LY3437943 (retatrutide), a triple agonist at GIP, GLP-1, and glucagon receptors
This process not only slows down hypoxia-induced endothelial cell senescence but also aids in restoring damaged endothelial cell function, offering new insights and potential intervention strategies for related diseases
It was first isolated in 1982 by Yves-Alain Barde and Hans Thoenen, and the decades since have revealed it to be one of the most important signaling molecules in the entire nervous system
Dose: 0.51 mg per day , subcutaneous Frequency: 35 times weekly Cycle: 8 weeks on / 4 weeks off , repeated indefinitely Stack: commonly run alongside NAD+ infusions and CJC-1295 / Ipamorelin for full anti-ageing coverage
These are metabolic sequelae, and they are largely preventable with appropriate intervention
Alcohol can independently cause both, especially in larger amounts